Pooja Adtani

Dr. Pooja Adtani

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2016 in Journal of Investigative and Clinical Dentistry
Verified
Journal Article
Closed access
PDF file
PAPooja Adtani
Pooja Adtani
MNMalathi Narasimhan
Malathi Narasimhan
APAlan M. Punnoose
Alan M. Punnoose
HKHimavanth Reddy Kambalachenu
Himavanth Reddy Kambalachenu

20 September 2022 in Acta Stomatologica Croatica
Verified
Journal Article
Open access
DSDusan Surdilovic
Dusan Surdilovic
PAPooja Adtani
Pooja Adtani
SFSura Ali Ahmed Fuoad
Sura Ali Ahmed Fuoad
HAHeba Abdelaal
Heba Abdelaal
JDJovita D’sOuza
Jovita D’sOuza
The Dunning-Kruger effect (cognitive bias) is a psychological phenomenon that implies that individuals with a lack of knowledge and skills have an unrealistically optimistic image of their abilities compared to others. The study aimed to examine the presence of the Dunning-Kruger effect in fifth (final) year dental undergraduate students at Gulf Medical University, UAE, in clinical domains related to pediatric dentistry. A longitudinal cohort study was conducted at Gulf Medical University, College of Dentistry, to evaluate cognitive bias among 5th-year dental students at GMU in the competency domains of communication, diagnosis, and clinical skills in Pediatric dentistry. Overall, compared to the level of confidence of students in September, there was a decline in the level of confidence in January. With an increase in time, the percentage shifted to a higher level in May across all domains. Characteristic patterns of fluctuations in students' self-confidence during clinical exposure are observed. The research results prove that the Dunning-Kruger effect, the cognitive bias of the perception pattern, is present in the examined group of dental students.

11 March 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
PAPooja Adtani
Pooja Adtani
SFSura Ali Ahmed Fuoad
Sura Ali Ahmed Fuoad
WEWalid Shaaban Elsayed
Walid Shaaban Elsayed
Background/Objectives: Oral squamous cell carcinoma (OSCC) is a significant global health concern, necessitating the development of novel treatment strategies. The present study investigated the in vitro anticancer activity of sulforaphane (SFN), an isothiocyanate derived from Brassica oleracea, on the OECM-1 human oral squamous carcinoma cell line. Methods: OECM-1 cells were cultured and exposed to a range of SFN concentrations. To assess the cell viability and determine the half maximal inhibitory concentration (IC50) of SFN following 24 h of treatment, an MTT assay was performed. Apoptosis was evaluated using AO/PI staining, a TUNEL assay, Annexin V-FITC analysis, and a DNA fragmentation assay. Changes in the mitochondrial membrane potential were analyzed using a JC-1 staining assay. A Western blot assay was performed to assess the expression levels of apoptosis-associated proteins (Bax, Bcl2, caspase-3, caspase-9, PARP, Smad-4, p53, cytochrome c, and GAPDH). Cell cycle analysis was performed to validate the apoptotic findings. Results: The IC50 concentration of SFN was 5.7 µM. The apoptotic assays demonstrated an effective induction of apoptosis in the OECM-1 cells. Western blot analysis demonstrated the dose-dependent upregulation of p53, caspase-3, caspase-9, PARP, cytochrome c, and Bax and the downregulation of the anti-apoptotic proteins Bcl-2 and Smad-4 after SFN treatment. Conclusions: The data obtained indicate that SFN has significant potential to induce apoptosis in OECM-1 cells by disrupting mitochondrial function and modulating apoptotic pathways. The outcomes of our research indicate SFN’s potential as a viable treatment drug for OSCC.

1 January 2018 in Translational Research in Oral Oncology
Verified
Journal Article
Open access
PDF file
PAPooja Adtani
Pooja Adtani
NMNarasimhan Malathi
Narasimhan Malathi
RKRanganathan Kannan
Ranganathan Kannan
SLSivaswamy Lokeswari
Sivaswamy Lokeswari
APAlan Mathew Punnoose
Alan Mathew Punnoose
To explore Ocimum basilicum L. (sweet basil) and linalool for their antifibrotic activity in an arecoline-induced in vitro fibrotic model. Leaf extract of O. basilicum L. (LEOB) and linalool were used as experimental agents to test their antifibrogenic activity in vitro. Half-maximal inhibitory concentration (IC50) for arecoline, ethanolic LEOB, and linalool was determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. To evaluate the antifibrotic effect of ethanolic LEOB and linalool on pretreatment, that is, both the testing agents were added to the human buccal fibroblasts (HBFs) prior to induction with arecoline, and reverse transcriptase polymerase chain reaction (RT-PCR) was carried out to study the response of transforming growth factor beta (TGFβ), collagen 1 subtype A2 (COL1A2), and collagen 3 subtype A1 (COL3A1). To appreciate the morphological alterations in HBFs on treatment with arecoline, ethanolic LEOB, and linalool, Masson’s trichrome staining was performed. Arecoline enhanced fibrotic activity by upregulating TGFβ1, COL1A2, and COL3A1 levels, whereas ethanolic LEOB and linalool on pretreatment significantly downregulated the increased levels of TGFβ1, COL1A2, and COL3A1 in primary HBF cell cultures. Both ethanolic LEOB and linalool exhibited significant antifibrotic activity in an in vitro model. Further studies in an in vitro model can help attain a foundation for an herbal formulation in gel form that can be prescribed to patients diagnosed with oral submucous fibrosis for topical application. It can also be used synergistically with Western medicine.

1 May 2019 in Journal of Oral and Maxillofacial Pathology
Verified
Journal Article
Open access
PDF file
PAPooja Adtani
Pooja Adtani
MNMalathi Narasimhan
Malathi Narasimhan
RKRanganathan Kannan
Ranganathan Kannan
APAlan Punnoose
Alan Punnoose
PPPrathibha Prasad
Prathibha Prasad
PNPrabhu Manickam Natarajan
Prabhu Manickam Natarajan
Background: Oral submucous fibrosis (OSMF) is a chronic debilitating condition of the oral mucosa that has been classified as a potentially malignant disorder with a malignant transformation rate of 2%–8%. Several in vitro and in vivo experiments have been performed to formulate a treatment modality for OSMF, yet no ideal in vitro primary oral fibroblast model has been developed. Aim: To establish an in vitro primary oral fibroblast model. Setting and Design: In vitro laboratory setting. Materials and Methodology: Primary cell culture protocol was performed after obtaining normal oral tissue. Karyotyping was performed to rule out chromosomal abnormalities. Immunofluorescence staining was carried with a panel of fibroblast-specific markers (vimentin, phalloidin, transforming growth factor-β receptor 1 [TGFβR1] and s100a4) and Masson trichrome staining (MTS) to demonstrate the presence of extracellular matrix (ECM) qualitatively. Results: A monolayer of oral fibroblasts was observed on the 9th-day postseeding. No chromosomal abnormality was observed in the patient samples. Positive staining was observed with vimentin, phalloidin, TGFβR1 and s100a4, thereby confirming the cell type. MTS revealed fibroblasts with spindle morphology and scanty ECM. Conclusion: The present study lays down a protocol to design and characterize primary buccal fibroblast cell culture model that would aid researchers in performing in vitro preliminary experiments in areas concerning fibrosis.

1 January 2015 in Journal of Oral and Maxillofacial Pathology
Verified
Journal Article
Open access
PDF file
PAPooja Adtani
Pooja Adtani
NMNarasimhan Malathi
Narasimhan Malathi
Context: Pathogenesis of autoimmune diseases (AD) is one of a multifactorial milieu. A genetic predisposition, an immune system failure, hormonal imbalance and environmental factors play important roles. Among the many environmental factors, the role of infection is gaining importance in the pathogenesis of various autoimmune disorders; among them, Epstein–Barr virus (EBV) plays a pivotal role. Literature states an association of various AD with EBV namely multiple sclerosis, autoimmune thyroiditis, systemic lupus erythematous, oral lichen planus (OLP), rheumatoid arthritis (RA), autoimmune hepatitis, Sjögren's syndrome and Kawasaki disease; among these, the most commonly occurring are OLP and RA. Aim: Considering the frequency of occurrences, our aim was to perform a qualitative analysis of EBV viral capsid antigen (EBV VCA) IgG in the sera of patients with RA, OLP and establish a comparison with normal. Settings and Design:In-vitro experiment in a research laboratory. Subjects and Methods: Five-milliliter blood sample was collected from 25 patients diagnosed with RA and OLP. Serum was separated and EBV VCA IgG antibody titer was detected using NovaTec EBV VCA IgG ELISA kit. Statistical Analysis Used: Chi-square test. Results: Six out of 25 subjects with RAand 4 out of 25 subjects with OLP tested positive for EBV VCA IgG. Conclusions: Both environmental and genetic factors are important contributory components for autoimmune conditions. Screening for viral etiology would improve the efficacy of conventional treatment and reduce the risk of relapses.